Skip to main content

Table 2 Statistical analysis of XMRV positivity in controls and PCa

From: No evidence of XMRV in prostate cancer cohorts in the Midwestern United States

 

No. a

Positiveb

x 2c

Non-PCad

40

1

0

PCae

110

5

0.319

  1. a Total number of samples tested from each Gleason score.
  2. b Number of PCR positive samples from each Gleason score.
  3. c Statistical results from chi-square (x2) tests.
  4. d Samples from benign/normal cancer patients.
  5. e Samples from prostate cancer patients.